Cargando...

How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients

Background: The literature suggests that medical oncologists differ on how they use the Oncotype DX (ODX) genomic assay for making decisions about systemic therapy in breast cancer patients. Given the emergence of data supporting the use of genomic profiling for the prognosis and predicting benefit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Curr Oncol
Main Authors: Zhu, Xiaofu, Dent, Susan, Paquet, Lise, Zhang, Tinghua, Tesolin, Daniel, Graham, Nadine, Aseyev, Olexiy, Song, Xinni
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7985759/
https://ncbi.nlm.nih.gov/pubmed/33557029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28010077
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!